Basic safety assessments indicated that gastrointestinal adverse situations, primarily nausea and diarrhea, ended up dose-dependent but typically gentle and transient. These conclusions recognized the therapeutic window and informed dose collection for subsequent Phase three trials.以下溶解方案都请先按照体外实验的方式配制澄清�